Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,569.60
(
0.05%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
102.12
(
0.58%
)
Bitcoin
77,722.07
(
-1.19%
)
News Focus
News Focus
Post# of 257443
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 50
Posts 5527
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 251779

Friday, 05/10/2024 12:09:41 PM

Friday, May 10, 2024 12:09:41 PM

Post# of 257443

$500M up-front cash



wow and congrats to anyone who is long didn't think they could get an up front like this
SNY must believe either that the NVAX platform can enable you to pick a flu strain on VERY short notice, or that it has some other advantage over MRNA tech, because if anything the one area where mRNA is expected to be better than current vaccines is flu bc you can pick a strain much closer to the flu season
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today